Language may feel like one of the most distinctly human things about you, but the genetic groundwork for it appears to be ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one-time gene silencing in the central nervous system AviadoBio will present k ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced four presentations of new preclinical data at the ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene W ...
April 27 (Reuters) - Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in patients with a rare genetic disorder in a late-stage trial ...
Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...
Genome editing is revolutionizing the medical landscape by offering new therapeutic possibilities for genetic diseases, which collectively affect hundreds ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
Scientists have identified two specific types of brain cells that behave differently in people with depression, offering a ...
The physical differences between men and women are all too obvious, but the biological divide goes right down to the cellular ...
March 25 (Reuters) - The U.S. Food and Drug Administration has approved Denali Therapeutics' (DNLI.O), opens new tab therapy to treat children with a rare genetic disorder, marking the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results